KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer
| author | |
| created | [InstanceEdit:9649305] Rothfels, Karen, 2019-06-12 |
| dbId | 9649300 |
| displayName | KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer |
| journal | Clin. Cancer Res. |
| pages | 2890-6 |
| pubMedIdentifier | 17504988 |
| schemaClass | LiteratureReference |
| title | KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer |
| url | http://www.ncbi.nlm.nih.gov/pubmed/17504988 |
| volume | 13 |
| year | 2007 |
Referrals
| (literatureReference) | |
| (author) |
© 2026 Reactome
